Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kaern

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Current Opinion in Obstetrics & Gynecology|February 1, 1996
Prognosis and management of borderline tumours of the ovaryC Tropé, J Kaern
Seminars in Oncology|June 20, 1998
Management of borderline tumors of the ovary: state of the artC Tropé, J Kaern
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2006
Primary surgery for ovarian cancerC Tropé, J Kaern
European Journal of Gynaecological Oncology|February 12, 1999
Carboplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-upT Paulsen, J Kaern, C Tropé
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Tamoxifen in the treatment of recurrent ovarian carcinomaC Tropé, C Marth, J Kaern
European Journal of Gynaecological Oncology|November 21, 2002
A phase II study of weekly paclitaxel in platinum and paclitaxel-resistant ovarian cancer patientsJ Kaern, M Baekelandt, C G Tropé
Cancer|March 1, 1993
A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalitiesJ Kaern, C G Tropé, V M Abeler
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomasC Tropé, J Kaern, I Vergote, et al.
Acta Ophthalmologica|June 1, 1984
A study of the incidence of neonatal conjunctivitis and of its bacterial causes including Chlamydia trachomatis. Clinical examination, culture and cytology of tear fluidI L Mølgaard, P B Nielsen, J Kaern
Acta Oncologica (Stockholm, Sweden)|July 27, 1999
Long-term follow-up of neoadjuvant cisplatin and 5-fluorouracil chemotherapy in bulky squamous cell carcinoma of the cervixC Marth, K Sundfor, J Kaern, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Current Opinion in Obstetrics & Gynecology|February 1, 1996
Prognosis and management of borderline tumours of the ovaryC Tropé, J Kaern
Seminars in Oncology|June 20, 1998
Management of borderline tumors of the ovary: state of the artC Tropé, J Kaern
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2006
Primary surgery for ovarian cancerC Tropé, J Kaern
European Journal of Gynaecological Oncology|February 12, 1999
Carboplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-upT Paulsen, J Kaern, C Tropé
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Tamoxifen in the treatment of recurrent ovarian carcinomaC Tropé, C Marth, J Kaern
European Journal of Gynaecological Oncology|November 21, 2002
A phase II study of weekly paclitaxel in platinum and paclitaxel-resistant ovarian cancer patientsJ Kaern, M Baekelandt, C G Tropé
Cancer|March 1, 1993
A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalitiesJ Kaern, C G Tropé, V M Abeler
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomasC Tropé, J Kaern, I Vergote, et al.
Acta Ophthalmologica|June 1, 1984
A study of the incidence of neonatal conjunctivitis and of its bacterial causes including Chlamydia trachomatis. Clinical examination, culture and cytology of tear fluidI L Mølgaard, P B Nielsen, J Kaern
Acta Oncologica (Stockholm, Sweden)|July 27, 1999
Long-term follow-up of neoadjuvant cisplatin and 5-fluorouracil chemotherapy in bulky squamous cell carcinoma of the cervixC Marth, K Sundfor, J Kaern, et al.
Pageof 7